Merck announced promising trial results this week, but the full data has yet to be released.
from Livescience.com https://ift.tt/3Fk45YX
via IFTTT
Jumat, 01 Oktober 2021
New antiviral pill halves risk of COVID-19 hospitalization, Merck says
Related Posts:
Why type A blood may increase COVID-19 risk- Decapitated Stone Age woman's head rolled into a cave in Italy
- Could a nuclear reactor help solve the mystery of Amelia Earhart's disappearance?
- Woman's foul-smelling 'turkey ear' caused by decades-long infection
- The Gulf Stream is slowing to a 'tipping point' and could disappear
0 komentar:
Posting Komentar